drugset / Trial / NCT07156253
Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
This interventional study will evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary efficacy of SYN818 with Olaparib in adult patients with locally advanced or metastatic solid tumors
Timeline
- Start
- 2025-08-26
- Primary completion
- 2028-08-25
- Completion
- 2029-02-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olaparib | Small molecule | — | Oral |
| Subject | SYN818 | Unknown | — | Oral |